TNF alpha Antibody, Rabbit, Polyclonal

Artikelname:	TNF alpha Antibody, Rabbit, Polyclonal
Artikelnummer:	ROC-209-401-306
Hersteller Artikelnummer:	209-401-306
Alternativnummer:	ROC-209-401-306
Hersteller:	Rockland Immunochemicals
Wirt:	Rabbit
Kategorie:	Antikörper
Applikation:	IF, IHC, WB
Spezies Reaktivität:	Human
Immunogen:	TNF alpha antibody used to produce this IgG fraction antibody was prepared by repeated immunizations with recombinant human TNFalpha.
Konjugation:	Unconjugated
Alternative Synonym:	APC1 antibody, Cachectin antibody, DIF antibody, Differentiation inducing factor antibody, Macrophage cytotoxic factor antibody, MCF antibody, Necrosin antibody, Tumour Necrosis Factor Alpha antibody, rabbit anti-Tumor Necrosis Factor Alpha Antibody, rabbit anti-TNF Alpha Antibody, Tumor necrosis factor, TNF-alpha, Tumor necrosis factor ligand superfamily member 2, TNF-a, Tumor necrosis factor membrane form, N-terminal fragment, NTF, Intracellular domain 1, ICD1, Intracellular domain 2, ICD2, C-domain 1, C-domain 2, Tumor necrosis factor, soluble form, TNF, TNFA, TNFSF2

Klonalität:	Polyclonal
Konzentration:	1.0 mg/mL by UV absorbance at 280 nm
NCBI:	7124
UniProt:	P01375
Puffer:	0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2
Formulierung:	Liquid (sterile filtered)
Target-Kategorie:	Human
Antibody Type:	Primary Antibody

Application Verdünnung:	ELISA: 1:1,000 - 1:5,000, IHC: 1:100 - 1:500, IF Microscopy: User Optimized, WB: 1:500 - 1:2,000
Anwendungsbeschreibung:	Anti-TNF alpha antibody has been tested in WB, ELISA, IF, and IHC. Expect a band in appropriate lysates at ~25.6kDa. This antibody is also useful for neutralization of human and primate TNFalpha activity in bioassays diluted at 1:200. The antibody does not r

	Fluorescent immunohistochemistry showing staining of human colon by Rocklands anti-TNF alpha (formalin/PFA-fixed paraffin-embedded sections). Samples were formaldehyde-fixed, then blocked in 10% serum for 2 hours at 20C. The primary antibody was diluted 1:100 and incubated with the sample for 2 hours at 20C. Alexa Fluor 680 goat polyclonal secondary antibody was used diluted 1:5000.

	Western blot using Rocklands Anti-Human TNF-a (RABBIT) Antibody. Membrane blocked in 1% BSA-TBS-T for 30 min at RT, Rb-a-TNF alpha added at 1:1000 in 1% BSA-TBS-T o/n 4C, DyLight 649 Gt-a-Rb (p/n 611-143-122) added at 1:20,000 in buffer (p/n MB-070) for 30 min at RT.
	Western Blot of Rabbit anti-TNF Alpha antibody. Marker: Opal Pre-stained ladder (p/n MB-210-0500). Lane 1: HEK293 lysate (p/n W09-000-365). Lane 2: HeLa Lysate (p/n W09-000-364). Lane 3: MCF-7 Lysate (p/n W09-000-360). Lane 4: Jurkat Lysate (p/n W09-000-370). Lane 5: A431 Lysate (p/n W09-000-361). Lane 6: A549 Lysate (p/n W09-001-372). Lane 7: LNCap Lysate (p/n W09-001-GJ9). Lane 8: MOLT-4 Lysate (p/n W09-001-GK2). Lane 9: Ramos Lysate (p/n W09-000-GK4). Lane 10: Raji Lysate (p/n W09-001-368). Lane 11: A-172 Lysate (p/n W09-001-GL5). Lane 12: NIH/3T3 Lysate (p/n W10-000-358). Load: 35 µg per lane. Primary antibody: TNF Alpha antibody at 1ug/mL overnight at 4C. Secondary antibody: Peroxidase rabbit secondary antibody (p/n 611-103-122) at 1:30,000 for 60 min at RT. Blocking Buffer: 1% Casein-TTBS (p/n MB-082) for 30 min at RT. Predicted/Observed size: 26kDa for TNF Alpha.
	(I) Immunostaining for TNF-a: (A) negative control, (B) muscle from subject 465 yr (positive control), (C) muscle from weight maintainer, and (D) muscle from weight gainer.Anti-human TNF-a antibody (p/n 209-401-306) at 1:50. The sites of peroxidase binding were demonstrated with diamonobenzidine (p/n DAB-50). Fig 2. PMID: 16687193.
	Immunohistochemistry using Rocklands polyclonal TNFa antibody showing staining of formalin/PFA-fixed paraffin-embedded sections of human artery tissue sections. Sections were fixed in formaldehyde and subjected to heat mediated antigen retrieval in citrate buffer (pH 6.0). Slides were blocked for ten minutes with 1.5% serum. Primary antibody was diluted 1:100 and incubated with samples for 24 hours at 4C. HRP-conjugated goat anti-rabbit antibody was used as the secondary antibody.